Analysis of VEGF-A regulated gene expression in endothelial cells to identify genes linked to angiogenesis

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Rivera, Corban G ^a,b   Mellberg, Sofie ^c   Claesson Welsh, Lena ^c   Bader, Joel S ^a,b   Popel, Aleksander S ^a  

^a Johns Hopkins University   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; ENDOGLIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; LIBERIN BETA1; LIPRIN BETA 1; MYOCYTE ENHANCER FACTOR 2; MYOCYTE ENHANCER FACTOR 2C; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN A; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CELL SURFACE RECEPTOR; ENDOTHELIAL PAS DOMAIN CONTAINING PROTEIN 1; ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1; ENG PROTEIN, HUMAN; HIF1A PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; MADS DOMAIN PROTEIN; MEF2C PROTEIN, HUMAN; MYOGENIC FACTOR; PPFIBP1 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANGIOGENESIS; ARTICLE; CELL CULTURE; CELL LINE; ENDOTHELIUM CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; HUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; VALIDATION STUDY; DRUG EFFECT; GENE EXPRESSION; METABOLISM; NEOVASCULARIZATION (PATHOLOGY);

HUMAN IMMUNODEFICIENCY VIRUS 1;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTIGENS, CD; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL LINE; ENDOTHELIAL CELLS; GENE EXPRESSION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MADS DOMAIN PROTEINS; MYOGENIC REGULATORY FACTORS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, CELL SURFACE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80052754504     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024887     Document Type: Article

References (35)

1. Folkman J, (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182-1186.
2. Folkman J, (2007) Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov 6: 273-286.
3. Garber K, (2002) Angiogenesis inhibitors suffer new setback. Nature biotechnology 20: 1067-1068.
4. Rehn M, Veikkola T, Kukk-Valdre E, Nakamura H, Ilmonen M, et al. (2001) Interaction of endostatin with integrins implicated in angiogenesis. Proceedings of the National Academy of Sciences of the United States of America 98: 1024.
5. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, et al. (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277: 55.
6. Murali TM, Wu CJ, Kasif S, (2006) The art of gene function prediction. Nat Biotechnol:- 24: 1474-1475; author reply 1475-1476.
7. Pena-Castillo L, Tasan M, Myers CL, Lee H, Joshi T, et al. (2008) A critical assessment of Mus musculus gene function prediction using integrated genomic evidence. Genome Biol 9 (Suppl 1): S2.
8. Zhou X, Kao MC, Wong WH, (2002) Transitive functional annotation by shortest-path analysis of gene expression data. Proc Natl Acad Sci U S A 99: 12783-12788.
9. Lanckriet GR, De Bie T, Cristianini N, Jordan MI, Noble WS, (2004) A statistical framework for genomic data fusion. Bioinformatics 20: 2626-2635.
10. Troyanskaya OG, Dolinski K, Owen AB, Altman RB, Botstein D, (2003) A Bayesian framework for combining heterogeneous data sources for gene function prediction (in Saccharomyces cerevisiae). Proceedings of the National Academy of Sciences 100: 8348.
11. Huang Y, Li S, (2010) Detection of characteristic sub pathway network for angiogenesis based on the comprehensive pathway network. BMC Bioinformatics 11: S32.
12. Gu J, Chen Y, Li S, Li Y, (2010) Identification of responsive gene modules by network-based gene clustering and extending: application to inflammation and angiogenesis. BMC systems biology 4: 47.
13. Chen Y, Wei T, Yan L, Lawrence F, Qian HR, et al. (2008) Developing and applying a gene functional association network for anti-angiogenic kinase inhibitor activity assessment in an angiogenesis co-culture model. BMC Genomics 9: 264.
14. Rivera CG, Bader JS, Popel AS, (2011) Angiogenesis-associated crosstalk between collagens, CXC chemokines, and thrombospondin domain-containing proteins. Ann Biomed Eng 39: 2213-2222.
15. Schweighofer B, Testori J, Sturtzel C, Sattler S, Mayer H, et al. (2009) The VEGF-induced transcriptional response comprises gene clusters at the crossroad of angiogenesis and inflammation. Thromb Haemost 102: 544-554.
16. Glesne DA, Zhang W, Mandava S, Ursos L, Buell ME, et al. (2006) Subtractive transcriptomics: establishing polarity drives in vitro human endothelial morphogenesis. Cancer Res 66: 4030-4040.
17. Mellberg S, Dimberg A, Bahram F, Hayashi M, Rennel E, et al. (2009) Transcriptional profiling reveals a critical role for tyrosine phosphatase VE-PTP in regulation of VEGFR2 activity and endothelial cell morphogenesis. FASEB J 23: 1490-1502.
18. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550.
19. NicAmhlaoibh R, Shtivelman E, (2001) Metastasis suppressor CC3 inhibits angiogenic properties of tumor cells in vitro. Oncogene 20: 270.
20. Maiti D, Xu Z, Duh EJ, (2008) Vascular endothelial growth factor induces MEF2C and MEF2-dependent activity in endothelial cells. Investigative ophthalmology & visual science 49: 3640.
21. ten Dijke P, Goumans MJ, Pardali E, (2008) Endoglin in angiogenesis and vascular diseases. Angiogenesis 11: 79-89.
22. Talks KL, Turley H, Gatter KC, Maxwell PH, Pugh CW, et al. (2000) The expression and distribution of the hypoxia-inducible factors HIF-1 {alpha} and HIF-2 {alpha} in normal human tissues, cancers, and tumor-associated macrophages. American Journal of Pathology 157: 411.
23. Koukourakis MI, Giatromanolaki A, Skarlatos J, Corti L, Blandamura S, et al. (2001) Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy. Cancer research 61: 1830.
24. Vagnucci AH, (2003) Alzheimer's disease and angiogenesis. The Lancet 361: 605-608.
25. Grammas P, Moore P, Weigel PH, (1999) Microvessels from Alzheimer's disease brains kill neurons in vitro. Am J Pathol 154: 337-342.
26. Lee SH, Wolf PL, Escudero R, Deutsch R, Jamieson SW, et al. (2000) Early expression of angiogenesis factors in acute myocardial ischemia and infarction. New England Journal of Medicine 342: 626-633.
27. Browder T, Folkman J, Pirie-Shepherd S, (2000) The hemostatic system as a regulator of angiogenesis. Journal of Biological Chemistry 275: 1521.
28. Jayapandian M, Chapman A, Tarcea VG, Yu C, Elkiss A, et al. (2007) Michigan Molecular Interactions (MiMI): putting the jigsaw puzzle together. Nucleic Acids Res 35: D566-571.
29. Vastrik I, D'Eustachio P, Schmidt E, Gopinath G, Croft D, et al. (2007) Reactome: a knowledge base of biologic pathways and processes. Genome Biol 8: R39.
30. Breitkreutz BJ, Stark C, Reguly T, Boucher L, Breitkreutz A, et al. (2008) The BioGRID Interaction Database: 2008 update. Nucleic Acids Res 36: D637-640.
31. Keshava Prasad TS, Goel R, Kandasamy K, Keerthikumar S, Kumar S, et al. (2009) Human Protein Reference Database-2009 update. Nucleic Acids Res 37: D767-772.
32. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29.
33. Liberzon A, Subramanian A, Pinchback R, Thorvaldsdottir H, Tamayo P, et al. (2011) Molecular signatures database (MSigDB) 3.0. Bioinformatics 27: 1739-1740.
34. Subramanian A, Kuehn H, Gould J, Tamayo P, Mesirov JP, (2007) GSEA-P: a desktop application for Gene Set Enrichment Analysis. Bioinformatics 23: 3251-3253.
35. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B (Methodological) pp. 289-300.